Page last updated: 2024-11-05

ici 204,219 and Hypereosinophilic Syndrome

ici 204,219 has been researched along with Hypereosinophilic Syndrome in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, D1
Saltoun, CA1

Other Studies

1 other study available for ici 204,219 and Hypereosinophilic Syndrome

ArticleYear
Facial swelling and eosinophilia in a 44-year-old woman.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2002, Volume: 89, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Diffe

2002